What is the first-line treatment for facial nerve paralysis?
Clinical scenario
Facial nerve paralysis is an acute peripheral facial palsy requiring prompt assessment and timely initiation of treatment. The window for effective intervention is narrow, making early clinical decision-making critical.
Treatment approach (partial overview)
The first-line approach involves systemic corticotherapy, initiated as early as possible after symptom onset. Alongside pharmacological management, systematic ophthalmologic care forms an essential part of the treatment plan.
The complete regimen — including agent selection, timing criteria, dosing strategy, and full ophthalmologic care protocol — is available in the structured evidence-based protocol below.
References
DOI: 10.1016/j.anorl.2020.06.004
- In Bell's palsy, corticotherapy with prednisolone or methylprednisolone should be implemented as early as possible (ideally, within 72 h).
- Bell's palsy should be treated by corticosteroids at 1 mg/kg/day for 7–10 days.
- Ophthalmologic treatment comprising local care, nocturnal occlusion and patient education should be systematic and as early as possible.
- They can be prevented by systematic administration of eye-drops, protective gel or artificial tears several times daily and especially at night.
View source ↗